The SAVE-COR project will introduce a new solution to identify the cardiac region where a patient’s arrhythmia originates. SAVE-COR stands for the stratification of atrial and ventricular arrhythmias based on electrocardiographic imaging.
SAVE-COR’s solution, ACORYS®, is a medical device which combines software (innovative 3D image processing technology) and hardware (a high-density set of 128 electrodes). The device non-invasively creates a detailed map of cardiac activity and identifies the origin of the arrhythmia.
ACORYS® is designed to help the clinicians through the entire patient journey, from diagnosis to a personalised treatment plan. The solution aims to increase ablation arrhythmia treatment efficacy and reduce mean arrhythmia treatment costs.
The device uses real-time global mapping in order to generate cardiac maps more quickly than traditional point-by-point catheter mapping methods. ACORYS® does not require any additional specialised equipment, for example, medical imaging devices. This makes it suitable for being used during routine consultations.
The SAVE-COR team plan to validate their device in four clinical studies involving more than 3000 arrhythmia patients at hospitals of Germany, Portugal, Spain and Sweden. Their objective is to obtain a CE mark, enter the market and become a recommended solution within the European arrhythmia management guidelines.
SAVE-COR’s solution aims to increase the efficacy rate of arrhythmia catheter ablation. This will improve patient outcomes and boost quality of life for citizens affected by arrhythmia. By improving treatment efficacy, this project aims to reduce the need for arrhythmia patients to under multiple interventions. This in turn would help to reduce the burden that arrhythmia treatment places on healthcare systems in Europe.
This research has received funding from the European Institute of Innovation and Technology (EIT) under grant agreement No 220385. This European body receives support from the Horizon 2020 research and innovation programme.